The Delay Isn't the Work. It's the Waiting.

Confidence: hypothesis. The timelines below are drawn from published research on trial start-up, not firsthand deployment. The pattern at the end is an argument, not a shipped system. Argue with it.

Reviewing a study budget is not a hundred-day task. Nobody spends fourteen weeks reading a spreadsheet. And yet, across a real pediatric trial, budget approval at different sites took anywhere from three days to five hundred and eighty five days. Same document type. Same review skill required at every site. A two-hundred-fold spread in how long it took.

That spread is the tell. When the same task, done by comparably trained people, produces wildly different completion times, the task itself is not the variable. The wait is.

The clinical why

The numbers come from the DOSE trial, a multi-site pediatric study whose start-up process was tracked and published in 2023. Average time to final budget approval was 121 days, but the range ran from 3 to 585. Average time to ethics-committee approval was 51 days, ranging from 1 to 205. Same protocol. Same budget template. Same regulatory requirement. The sites at the fast end and the sites at the slow end were not doing different amounts of work. They were sitting in different amounts of queue.